Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XVI.u

Imaging: A miliary pattern (diffuse random micronodules)

Publications

Green DB, Kawashima A, Menias CO, Tanaka T, Redelman-Sidi G, Bhalla S, Shah R, King BF

Complications of Intravesical BCG Immunotherapy for Bladder Cancer.

Radiographics : a review publication of the Radiological Society of North America, Inc. 2019;39(1):80-94

Julius D, Geerdes Fenge HF, Weber MA

[Dyspnea after instillation therapy for bladder cancer].

Der Radiologe. 2018;58(5):482-486

Kaburaki K, Sugino K, Sekiya M, Takai Y, Shibuya K, Homma S

Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.

Internal medicine (Tokyo, Japan). 2017;56(12):1563-1567

Choi CH, Lee SO, Smith G

Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

BMJ case reports. 2014;2014

Rabe J, Neff KW, Lehmann KJ, Mechtersheimer U, Georgi M

Miliary tuberculosis after intravesical bacille Calmette-Guérin immunotherapy for carcinoma of the bladder.

AJR. American journal of roentgenology. 1999;172(3):748-50

Jasmer RM, McCowin MJ, Webb WR

Miliary lung disease after intravesical bacillus Calmette-Guérin immunotherapy.

Radiology. 1996;201(1):43-4

Reinert KU, Sybrecht GW

T helper cell alveolitis after bacillus Calmette-Guerin immunotherapy for superficial bladder tumor.

The Journal of urology. 1994;151(6):1634-7